ほか

529 total citations
80 papers, 400 citations indexed

About

ほか is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, ほか has authored 80 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in ほか's work include Gastric Cancer Management and Outcomes (6 papers), Intraperitoneal and Appendiceal Malignancies (6 papers) and Colorectal Cancer Treatments and Studies (6 papers) ほか is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Intraperitoneal and Appendiceal Malignancies (6 papers) and Colorectal Cancer Treatments and Studies (6 papers) ほか collaborates with scholars based in Japan, Switzerland and United States ほか's co-authors include D. Coutsouradis and has published in prestigious journals such as Liver Cancer and Medical Entomology and Zoology.

In The Last Decade

ほか

46 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
ほか Japan	4	241	153	111	93	42	80	400
Nikola Ilić Serbia	11	146 0.6×	67 0.4×	97 0.9×	46 0.5×	232 5.5×	87	526
K Kubota Japan	8	191 0.8×	50 0.3×	141 1.3×	44 0.5×	11 0.3×	13	403
Kensuke Yokoyama Japan	9	83 0.3×	136 0.9×	58 0.5×	32 0.3×	101 2.4×	24	367
J. S. Wolf United States	5	133 0.6×	175 1.1×	199 1.8×	43 0.5×	57 1.4×	6	407
David Hull United States	8	130 0.5×	40 0.3×	42 0.4×	168 1.8×	17 0.4×	22	403
L. D’Angelo Italy	11	116 0.5×	12 0.1×	51 0.5×	25 0.3×	68 1.6×	35	405
Zipeng Xu China	11	51 0.2×	20 0.1×	80 0.7×	51 0.5×	50 1.2×	34	389
Sandeep Singh India	10	49 0.2×	33 0.2×	45 0.4×	27 0.3×	7 0.2×	31	421
Shaoheng Sun China	10	185 0.8×	27 0.2×	149 1.3×	59 0.6×	20 0.5×	20	391
Z.Y. Zhang China	9	104 0.4×	39 0.3×	77 0.7×	22 0.2×	29 0.7×	20	322

Countries citing papers authored by ほか

Since Specialization

Citations

This map shows the geographic impact of ほか's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ほか with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ほか more than expected).

Fields of papers citing papers by ほか

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ほか. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ほか. The network helps show where ほか may publish in the future.

Co-authorship network of co-authors of ほか

This figure shows the co-authorship network connecting the top 25 collaborators of ほか. A scholar is included among the top collaborators of ほか based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ほか. ほか is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

ほか, et al.. (2020). Randomized, Double-Blind, Placebo-Controlled Phase II Study on the Efficacy and Safety of Vitamin K1 Ointment for Cetuximab or Panitumumab-Induced Acneiform Eruptions―VIKTORIA Study. 47(6). 933–939. 1 indexed citations

2.

ほか, et al.. (2017). がん薬物療法と腎障害―白金製剤（シスプラチン，カルボプラチン)―. 44(3). 200–203.

3.

ほか, et al.. (2016). GEM＋nab-PTXによる術前化学療法が奏効したBorderline Resectable（BR）膵癌の1 切除例. 43(12). 1978–1981.

4.

ほか, et al.. (2014). Modified Administration Schedule of Docetaxel, Cisplatin, and Fluorouracil for Advanced or Recurrent Gastric Cancer with Gastrointestinal Stenosis. 41(10). 1227–1230. 1 indexed citations

5.

ほか, et al.. (2014). Novel Method of Determination of D9-Tetrahydrocannabinol（THC） in Human Serum by High-Performance Liquid Chromatography with Electrochemical Detection. 41(4). 471–473. 1 indexed citations

6.

ほか, et al.. (2013). 軽度および中等度アルツハイマー型認知症患者を対象としたリバスチグミンパッチの漸増期間中における有効性に関する経時的評価（国内第IIb/III相試験における事後解析）. 31(6). 101–107. 1 indexed citations

7.

ほか, et al.. (2013). 高CEA 血症を呈したLow─Grade Appendiceal Mucinous Neoplasm（LAMN）による腸重積に対し腹腔鏡下に治療した1 例. 40(12). 1944–1946. 1 indexed citations

8.

ほか, et al.. (2012). トラクリア錠62.5mg（ボセンタン水和物）特定使用成績調査における安全性と有効性（中間報告）. 30(2). 141–156. 1 indexed citations

9.

ほか, et al.. (2011). 遺伝性血管性浮腫（hereditary angioedema； HAE）—疾患概要と疾患認知度全国調査—Hereditary angioedema recognition survey in Japan（研究）. 29(2). 109–118. 4 indexed citations

10.

ほか, et al.. (2009). A Case of Advanced Mucinous Cystadenocarcinoma of the Pancreas with Peritoneal Dissemination Responding to Gemcitabine. 36(6). 995–998.

11.

ほか, et al.. (2009). 冠動脈インターベンション（PCI）施行後の二次予防における積極的脂質管理の有用性についての検討；新たな脂質管理目標値としてのLDL-C/HDL-C比の提案（研究）. 27(11). 93–99. 2 indexed citations

12.

ほか, et al.. (2008). A Case of Advanced Breast Cancer Associated with Development of Liver Atrophy with Progressive Liver Failure during Treatment. 35(6). 983–986. 1 indexed citations

13.

ほか, et al.. (2008). Bowel Perforation Associated with Bevacizumab Therapy in Recurrent Ovarian Cancers without Bowel Obstruction or Bowel Involvement. 35(11). 1981–1984. 1 indexed citations

14.

ほか, et al.. (2007). Imatinib Mesilate（Glivec）が著効した再発食道GIST の1例. 34(2). 237–240. 1 indexed citations

15.

ほか, et al.. (2006). 画像上脂肪を認めず診断困難であった肝血管筋脂肪腫の 1 例. Liver Cancer. 12(2). 147–153. 1 indexed citations

16.

ほか, et al.. (2005). TS-1 の経胃瘻投与における薬物動態および有害事象の検討. 32(6). 859–862. 1 indexed citations

17.

ほか, et al.. (2005). 胃全摘術後TS-1 を経管栄養カテーテルから投与した胃癌の1 例. 32(7). 1033–1036. 1 indexed citations

18.

ほか, et al.. (2004). Imatinib Mesylate による Neoadjuvant Therapy が有効であった胃GIST症例. 31(8). 1219–1223. 4 indexed citations

19.

ほか, et al.. (2004). National Cancer Institute-Common Toxicity Criteria(NCI-CTC Version 2.0）日本語訳JCOG版の信頼性の検討. 31(8). 1187–1192. 35 indexed citations

20.

ほか, et al.. (2004). Danenberg Tumor Profile法による大腸癌におけるTSおよびDPD mRNA発現量の検討. 31(6). 889–892.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact